A Landscape of CRISPR/Cas Technique for Emerging Viral Disease Diagnostics and Therapeutics: Progress and Prospects
Open Access
Abstract
Viral diseases have emerged as a serious threat to humanity and as a leading cause of morbidity worldwide. Many viral diagnostic methods and antiviral therapies have been developed over time, but we are still a long way from treating certain infections caused by viruses. Acquired immunodeficiency syndrome (AIDS) is one of the challenges where current medical science advancements fall short. As a result, new diagnostic and treatment options are desperately needed. The CRISPR/Cas9 system has recently been proposed as a potential therapeutic approach for viral disease treatment. CRISPR/Cas9 is a specialised, effective, and adaptive gene-editing technique that can be used to modify, delete, or correct specific DNA sequences. It has evolved into an advanced, configurable nuclease-based single or multiple gene-editing tool with a wide range of applications. It is widely preferred simply because its operational procedures are simple, inexpensive, and extremely efficient. Exploration of infectious virus genomes is required for a comprehensive study of infectious viruses. Herein, we have discussed the historical timeline-based advancement of CRISPR, CRISPR/Cas9 as a gene-editing technology, the structure of CRISPR, and CRISPR as a diagnostic tool for studying emerging viral infections. Additionally, utilizing CRISPR/Cas9 technology to fight viral infections in plants, CRISPR-based diagnostics of viruses, pros, and cons, and bioethical issues of CRISPR/Cas9-based genomic modification are discussed.Keywords
This publication has 182 references indexed in Scilit:
- Characterization of CRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludisNucleic Acids Research, 2012
- Evolution and classification of the CRISPR–Cas systemsNature Reviews Microbiology, 2011
- Update on Human Immunodeficiency Virus (HIV)-2 InfectionClinical Infectious Diseases, 2011
- Envelope stress is a trigger of CRISPR RNA-mediated DNA silencing in Escherichia coliMolecular Microbiology, 2010
- A dual function of the CRISPR–Cas system in bacterial antivirus immunity and DNA repairMolecular Microbiology, 2010
- Sequence- and Structure-Specific RNA Processing by a CRISPR EndonucleaseScience, 2010
- CRISPR/Cas, the Immune System of Bacteria and ArchaeaScience, 2010
- RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein ComplexCell, 2009
- Oncogenic activities of human papillomavirusesVirus Research, 2009
- CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNAScience, 2008